Product Information
NAFTIN 2% GEL is a brand product labeled by Sebela Pharmaceuticals Inc., priced at $10.8738 per GM under NDC 54766077260. Its NADAC has been published 417 times since Apr 25, 2018.
FDA first approved this application on Jun 27, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 g/100g
Manufacturer
Sebela Pharmaceuticals Inc.NDC
54766077260
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
4/4/2025
Active Ingredients
NAFTIFINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA204286FDA Approved
6/27/2013
TE Code
AB
On Market Since
3/1/2018
Pharmacological Classes
Price Statistics
The NADAC for NAFTIN 2% GEL has been published 417 times since Apr 25, 2018, and over the history we have for it it has risen 32.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.8738 per GM |
|---|---|
| All-time high | $10.8738 (Apr 15, 2026) |
| All-time low | $8.2348 (Apr 25, 2018) |
| 52-week high | $10.8738 |
| 52-week low | $10.8738 |
| Median price | $9.7518 |
| Average price | $9.6512 |
| Largest weekly change | +5.0% (Jan 15, 2020) |
| Weeks tracked | 417 |
| Tracking since | Apr 25, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
+8.3%
5Y
+14.9%
All
+32.0%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sebela Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naftifine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Allylamine Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAFTIN 2% GEL?
The current National Average Drug Acquisition Cost (NADAC) for NAFTIN 2% GEL, manufactured by Sebela Pharmaceuticals Inc., is $10.8738 per GM (NDC 54766077260), effective Apr 15, 2026.
How has the price of NAFTIN 2% GEL changed over time?
Over the history we have for it, the NADAC for NAFTIN 2% GEL has risen 32.0%. It has been tracked across 417 weekly CMS publications since Apr 25, 2018.
What are the highest and lowest recorded NADAC prices for NAFTIN 2% GEL?
Since Apr 25, 2018, the NADAC for NAFTIN 2% GEL has ranged from a low of $8.2348 (Apr 25, 2018) to a high of $10.8738 (Apr 15, 2026), with a median of $9.7518 per GM.
Are there cheaper alternatives to NAFTIN 2% GEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NAFTIN 2% GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures NAFTIN 2% GEL?
NAFTIN 2% GEL (NDC 54766077260) is labeled by Sebela Pharmaceuticals Inc., and CMS classifies it as a brand product.